Skip to main content
Abbott Laboratories
Healthcare · Medical Devices
Made on Aug 4, 2026
Price at call $107.12
6-month call Bear -7.6%
Target by Feb 2027 $99.00
Great value below $88.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -7.6% to $99.00
Predicted High $107.40 in 2 weeks
Predicted Low $99.00 at 6 months
Max Drawdown (predicted) -7.6%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 4, 2026 1:15 am
Bear ABT trends lower to $99.00 (-7.6% from $107.12) by Feb 2027. decay
ThesisABT trades meaningfully above composite fair value ($76-86) but quality is solid and momentum benign; expect gradual mean-reversion pressure toward high-90s over 6 months, with modest near-term drift as risk-on regime supports the tape.
Invalidated ifBreak above $112 on volume or a surprise pipeline/M&A catalyst invalidates the drift-lower thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $107.12 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 4, 2026 $107.12 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 18, 2026 $99.96–$114.28 typical range · internal point $107.40 ±6.7% 7/10 Risk-on regime, low vol, no near-term catalyst
What actually happened: closed $110.37 on Aug 17, 2026 = +3.0% vs the call (predicted +0.3%)  ·  direction HIT (called flat, was flat)  ·  off by 2.8 pp  ·  accuracy 9/10  ·  typical range ±6.7%: inside the band  ·  S&P +0.6% over the same window — lagged it
1 month Sep 4, 2026 $96.75–$117.49 typical range · internal point $106.50 ±9.7% 6/10 Mild drift as valuation gravity begins
2 months Oct 4, 2026 $105.00 -2.0% 5/10 Q3 print approaches, positioning cautious
3 months Nov 4, 2026 $103.50 -3.4% 5/10 Earnings likely beat but guidance caps upside
4 months Dec 4, 2026 $102.00 -4.8% 4/10 Year-end rotation away from defensives
5 months Jan 4, 2027 $100.50 -6.2% 4/10 Value gravity toward anchored-PE fair value
6 months Feb 4, 2027 $99.00 -7.6% 4/10 Convergence toward signal-adjusted fair value zone

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $103.09 (-3.8%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$107.12
Composite fair value$76.48
Signal-adjusted fair value$85.79
DCF fair value$73.94
Anchored-PE fair value$110.08
Buy-below (value lens)$88.00
Value net score-66
Value confidence7 / 10
Quality net score+67
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 41.7%  3m 33.5%  6m 29.5%  
Daily σ (realism noise)2.1%
Beta vs S&P 500 1m -1.16  3m -0.47  5m 0.05  
Trailing 6-month return-2.0%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 4, 2026 freshest ABT-20260804-002339-ea47
ext-forensic-memo Aug 4, 2026 freshest ext-ABT-20260804-005942-3369
ext-lens-quality Aug 4, 2026 freshest ext-ABT-20260804-005942-3369
ext-lens-sentiment Aug 4, 2026 freshest ext-ABT-20260804-005942-3369
ext-lens-value Aug 4, 2026 freshest ext-ABT-20260804-005942-3369
scenario-valuation Aug 4, 2026 freshest ABT-20260804-002339-ea47
valuation-synthesis Aug 4, 2026 freshest ABT-20260804-002339-ea47

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 4, 2026 v0.6.0 Bear $107.12 $99.00 -7.6% Feb 2027 viewing
Jun 28, 2026 v0.3.0 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.